Catalog No.:AA000JMO

1228943-80-3 | 2-Chloro-4,4-dimethylcyclohex-1-enecarbaldehyde

Name: Name:2-Chloro-4,4-dimethylcyclohex-1-enecarbaldehyde
Brand: AABLOCKS
SKU: AA000JMO
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

100mg

95%

in stock

$61.00 $43.00

- +

250mg

95%

in stock

$104.00 $73.00

- +

500mg

95%

in stock

$159.00 $111.00

- +

95%

in stock

$269.00 $189.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA000JMO

Chemical Name:

2-Chloro-4,4-dimethylcyclohex-1-enecarbaldehyde

CAS Number:

1228943-80-3

Molecular Formula:

C9H13ClO

Molecular Weight:

172.6519

MDL Number:

MFCD24687002

SMILES:

O=CC1=C(Cl)CC(CC1)(C)C

Properties

Downstream Synthesis Route

1228943-80-3

1679-18-1

1228837-05-5

[1]CurrentPatentAssignee:JIANGSUZHONGBANGPHARMACEUTICAL-CN108997333,2018,ALocationinpatent:Paragraph0055;0058;0059

[2]CurrentPatentAssignee:ABBVIEINC-US2010/160322,2010,A1Locationinpatent:Page/Pagecolumn107

[3]CurrentPatentAssignee:ABBVIEINC-US2014/275540,2014,A1Locationinpatent:Paragraph0144

[4]CurrentPatentAssignee:VIATRISINC-WO2018/29711,2018,A2Locationinpatent:Page/Pagecolumn27

[5]CurrentPatentAssignee:ABBVIEINC-US10213433,2019,B2Locationinpatent:Page/Pagecolumn211-212

[6]CurrentPatentAssignee:BEIGENELTD.-WO2019/210828,2019,A1Locationinpatent:Paragraph1101;1102

[7]CurrentPatentAssignee:MSNLABORATORIESPRIVATELIMITED-WO2020/49599,2020,A1Locationinpatent:Page/Pagecolumn28-29

[8]CurrentPatentAssignee:SHENYANGPHARMACEUTICALUNIVERSITY-CN111777626,2020,ALocationinpatent:Paragraph0050;0093-0096

[9]CurrentPatentAssignee:PRELUDETHERAPEUTICSINCORPORATED-US2021/346405,2021,A1Locationinpatent:Paragraph0451-0452

2979-19-3

33513-42-7

1228943-80-3

[1]CurrentPatentAssignee:JIANGSUZHONGBANGPHARMACEUTICAL-CN108997333,2018,ALocationinpatent:Paragraph0055;0058;0059

[2]CurrentPatentAssignee:ABBVIEINC-US2010/160322,2010,A1Locationinpatent:Page/Pagecolumn106;107

[3]CurrentPatentAssignee:ABBVIEINC-US2014/275540,2014,A1Locationinpatent:Paragraph0142;0143

[4]CurrentPatentAssignee:VIATRISINC-WO2018/29711,2018,A2Locationinpatent:Page/Pagecolumn27

[5]CurrentPatentAssignee:ABBVIEINC-US10213433,2019,B2Locationinpatent:Page/Pagecolumn211

[6]CurrentPatentAssignee:BEIGENELTD.-WO2019/210828,2019,A1Locationinpatent:Paragraph1099;1100

[7]CurrentPatentAssignee:MSNLABORATORIESPRIVATELIMITED-WO2020/49599,2020,A1Locationinpatent:Page/Pagecolumn28

[8]CurrentPatentAssignee:SHENYANGPHARMACEUTICALUNIVERSITY-CN111777626,2020,ALocationinpatent:Paragraph0050;0089-0092

[9]CurrentPatentAssignee:SINOBIOPHARMACEUTICALLIMITED-EP3858832,2021,A1Locationinpatent:Paragraph0120-0121

[10]CurrentPatentAssignee:PRELUDETHERAPEUTICSINCORPORATED-US2021/346405,2021,A1Locationinpatent:Paragraph0449-0450

1228943-80-3

1228780-71-9

[1]CurrentPatentAssignee:ABBVIEINC-US2014/275540,2014,A1

[2]CurrentPatentAssignee:MSNLABORATORIESPRIVATELIMITED-WO2020/49599,2020,A1

1228943-80-3

1-((4′-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-1,1′-biphenyl-2-yl)methyl)piperazinedihydrochloride

[1]CurrentPatentAssignee:ABBVIEINC-US2014/275540,2014,A1

1228943-80-3

tert-butyl2-((1H-pyrrolo2,3-bpyridin-5-yl)-oxy)-4-(4-((4′-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-1,1′-biphenyl-2-yl)methyl)piperazin-1-yl)benzoate

[1]CurrentPatentAssignee:ABBVIEINC-US2014/275540,2014,A1

[2]CurrentPatentAssignee:SHENYANGPHARMACEUTICALUNIVERSITY-CN111777626,2020,A

Literature

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS